BioCentury | Aug 31, 2009
Clinical News

Dengue fever vaccine: Phase I started

...placebo-controlled, U.S. Phase I trial to evaluate 3 doses of 10 or 50 µg intramuscular HBV-001 D1...
...16 healthy adult volunteers. Hawaii Biotech Inc. , Aiea, Hawaii Product: Dengue fever vaccine ( HBV-001 D1...
Items per page:
1 - 1 of 1